Prestige Brands (NYSE: PBH) is acquiring a portfolio of 17 OTC pharmaceutical brands from GlaxoSmithKline (NYSE: GSK) for $661.6 million. This acquisition, valued at 3.2x 2010 revenue, raises the buyer’s annual revenue from OTC brands to the range of $500.0 million,...
In January’s largest Biotechnology deal, Amgen, Inc. (NASDAQ: AMGN) is acquiring Micromet, Inc. (NASDAQ: MITI) for approximately $1.16 billion. Based in Rockville, Maryland, MITI discovers, develops and commercializes antibody-based therapeutics to treat cancer. On a...
Brought to you by www.DealSearchOnline.com February 13, 2012 Issue: Recent Health Care M&A Deals 2012 M&A Sprints Out Of Gate– Posts Record Deal Volume In January Spotlight on: Biotechnology Conference Calendar Recent Health Care M&A...
Posts Record Deal Volume In January January inaugurated a robust health care merger and acquisition market by posting 95 deals worth a combined total of $17.2 billion. Deal volume, in particular, reached its highest level in over a decade. This figure represents a...
Brought to you by www.DealSearchOnline.com February 6, 2012 Issue: Recent Health Care M&A Deals Spotlight on: Hospitals Spotlight on: E-Health Conference Calendar Recent Health Care M&A Deals Biotechnology Acquirer Target Price Cytomedix, Inc. Aldagen,...
Eight hospital deals were announced but only one came with a price tag. As MedCath (NASDAQ: MDTH) continues to wind down, it sold Louisiana Medical Center and Heart Hospital, a 137-bed acute care facility in Lacombe, to Nashville-based Cardiovascular Care Group (CCG)....